8-K Filing

Company

Cocrystal Pharma, Inc.

Filed

September 14, 2021

Period of Report

September 12, 2021

Accession Number

0001493152-21-022690

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →